Yi Wu

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Loss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4.

Loss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4.

Journal: International journal of molecular sciences

Published: July 14, 2026

Pancancer Analysis and the Oncogenic Role of UBTF in Breast Invasive Carcinoma.

Pancancer Analysis and the Oncogenic Role of UBTF in Breast Invasive Carcinoma.

Journal: International journal of molecular sciences

Published: January 31, 2026

Integrated Single-Cell Analysis Identifies IL1RAP as a Master Regulator of TAMs and a Prognostic Biomarker in Breast Cancer.

Integrated Single-Cell Analysis Identifies IL1RAP as a Master Regulator of TAMs and a Prognostic Biomarker in Breast Cancer.

Journal: International journal of molecular sciences

Published: January 17, 2026

The KRT15 and KRT81 complex promotes lenvatinib resistance in thyroid cancer by upregulating DGKB mediated lipid metabolism.

The KRT15 and KRT81 complex promotes lenvatinib resistance in thyroid cancer by upregulating DGKB mediated lipid metabolism.

Journal: Scientific reports

Published: May 15, 2025

Astrocyte Secretome Profiling via Biorthogonal Labeling Unveils Novel Factors Relevant to Neurodegenerative Diseases.

Astrocyte Secretome Profiling via Biorthogonal Labeling Unveils Novel Factors Relevant to Neurodegenerative Diseases.

Journal: Glia

Published: March 04, 2025

5-Hydroxytryptamine G-Protein-Coupled Receptor Family Genes: Key Players in Cancer Prognosis, Immune Regulation, and Therapeutic Response.

5-Hydroxytryptamine G-Protein-Coupled Receptor Family Genes: Key Players in Cancer Prognosis, Immune Regulation, and Therapeutic Response.

Journal: Genes

Published: October 31, 2024

Clinical value of complete blood count ratio in benign and malignant thyroid diseases.

Clinical value of complete blood count ratio in benign and malignant thyroid diseases.

Journal: Cancer epidemiology

Published: May 10, 2024

IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion.

IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion.

Journal: Oncogene

Published: August 06, 2023

SIRT6 drives sensitivity to ferroptosis in anaplastic thyroid cancer through NCOA4-dependent autophagy.

SIRT6 drives sensitivity to ferroptosis in anaplastic thyroid cancer through NCOA4-dependent autophagy.

Journal: American journal of cancer research

Published: November 18, 2022

The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma.

The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma.

Journal: BMC surgery

Published: July 12, 2022

Thyroid cancer and its associations with dietary quality in a 1:1 matched case-control study.

Thyroid cancer and its associations with dietary quality in a 1:1 matched case-control study.

Journal: The British journal of nutrition

Published: April 20, 2022

Early functional exercise and functional rehabilitation of affected limbs in patients with breast cancer.

Early functional exercise and functional rehabilitation of affected limbs in patients with breast cancer.

Journal: Minerva surgery

Published: October 29, 2021

Showing 1-12 of 36

Last Updated: 09/26/2026